BioNexus Gene Lab Corp (BGLC): Net Income
-$2.98M
Year ended 2025-12-31
-$2.58M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$2.98M | n/m | 2026-04-14, From 2025-01-01 |
| 2024-12-31 | -$1.60M | n/m | 2026-04-14, From 2024-01-01 |
| 2023-12-31 | -$2.63M | n/m | 2025-04-15, From 2023-01-01 |
| 2022-12-31 | -$356.0K | n/m | 2024-04-16, From 2022-01-01 |
| 2021-12-31 | $751.6K | -31.3% | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | $1.09M | n/m | 2022-04-06, From 2020-01-01 |
| 2019-12-31 | -$246.5K | n/m | 2021-03-30, From 2019-01-01 |
| 2018-12-31 | $26.5K | n/a | 2020-03-31, From 2018-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| BioNexus Gene Lab Corp (BGLC) | 2025-12-31 | -$2.98M | n/m |
| American Shared Hospital Services (AMS) | 2025-12-31 | -$1.55M | n/m |
| Exagen Inc. (XGN) | 2025-12-31 | -$19.95M | n/m |
| Personalis, Inc. (PSNL) | 2025-12-31 | -$81.27M | n/m |
| Biodesix Inc (BDSX) | 2025-12-31 | -$35.27M | n/m |
| YD Bio Ltd (YDES) | 2025-12-31 | -$8.31M | n/m |
| GRAIL, Inc. (GRAL) | 2025-12-31 | -$408.35M | n/m |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $7.45M | n/m |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | -$60.51M | n/m |
Compare BGLC, AMS, XGN, PSNL side by side · Screen every company in Services-Medical Laboratories ↗